PURPOSE:Acetaminophen (APAP) protein adducts are a biomarker of APAP metabolism, reflecting oxidation of APAP and generation of the reactive metabolite N-acetyl-p-benzoquinone imine. High levels of adducts correspond to liver toxicity in patients with APAP-related acute liver failure. Adduct formation following low-dose exposure to APAP has not been well studied. APAP protein adducts were measured in blood samples collected from fasted individuals who participated in a crossover study of APAP (80 mg/kg) comparing extended release (ER) and immediate release (IR) formulations. METHODS: Adducts were quantified in all postdose blood samples using a validated high-performance liquid chromatography electrochemical detection (HPLC-EC) assay. RESULTS: Comparison of pharmacokinetic parameters for adducts did not reveal significant differences between ER and IR formulations, with one exception. Formation rates for adducts were faster for IR than the ER formulation (0.420 ± 0.157 vs. 0.203 ± 0.080 1/h), respectively. Maximum plasma concentrations (Cmax) of adducts for IR and ER were 0.108 (±0.020) and 0.100 (±0.028) nmol/ml serum, respectively, and were two orders of magnitude lower than adduct levels previously reported in adults with acute liver failure secondary to APAP. CONCLUSIONS:APAP protein adducts are rapidly formed following nontoxic ingestion of APAP at levels significantly lower than those associated with acute liver failure.
RCT Entities:
PURPOSE:Acetaminophen (APAP) protein adducts are a biomarker of APAP metabolism, reflecting oxidation of APAP and generation of the reactive metabolite N-acetyl-p-benzoquinone imine. High levels of adducts correspond to liver toxicity in patients with APAP-related acute liver failure. Adduct formation following low-dose exposure to APAP has not been well studied. APAP protein adducts were measured in blood samples collected from fasted individuals who participated in a crossover study of APAP (80 mg/kg) comparing extended release (ER) and immediate release (IR) formulations. METHODS: Adducts were quantified in all postdose blood samples using a validated high-performance liquid chromatography electrochemical detection (HPLC-EC) assay. RESULTS: Comparison of pharmacokinetic parameters for adducts did not reveal significant differences between ER and IR formulations, with one exception. Formation rates for adducts were faster for IR than the ER formulation (0.420 ± 0.157 vs. 0.203 ± 0.080 1/h), respectively. Maximum plasma concentrations (Cmax) of adducts for IR and ER were 0.108 (±0.020) and 0.100 (±0.028) nmol/ml serum, respectively, and were two orders of magnitude lower than adduct levels previously reported in adults with acute liver failure secondary to APAP. CONCLUSIONS:APAP protein adducts are rapidly formed following nontoxic ingestion of APAP at levels significantly lower than those associated with acute liver failure.
Authors: Kenneth L Muldrew; Laura P James; Leslie Coop; Sandra S McCullough; Howard P Hendrickson; Jack A Hinson; Philip R Mayeux Journal: Drug Metab Dispos Date: 2002-04 Impact factor: 3.922
Authors: Timothy J Davern; Laura P James; Jack A Hinson; Julie Polson; Anne M Larson; Robert J Fontana; Ezmina Lalani; Santiago Munoz; A Obaid Shakil; William M Lee Journal: Gastroenterology Date: 2006-03 Impact factor: 22.682
Authors: L P James; E V Capparelli; P M Simpson; L Letzig; D Roberts; J A Hinson; G L Kearns; J L Blumer; J E Sullivan Journal: Clin Pharmacol Ther Date: 2008-10-15 Impact factor: 6.875
Authors: Laura P James; Lynda Letzig; Pippa M Simpson; Edmund Capparelli; Dean W Roberts; Jack A Hinson; Timothy J Davern; William M Lee Journal: Drug Metab Dispos Date: 2009-05-13 Impact factor: 3.922
Authors: D W Roberts; T J Bucci; R W Benson; A R Warbritton; T A McRae; N R Pumford; J A Hinson Journal: Am J Pathol Date: 1991-02 Impact factor: 4.307
Authors: Kennon J Heard; Jody L Green; Laura P James; Bryan S Judge; Liza Zolot; Sean Rhyee; Richard C Dart Journal: BMC Gastroenterol Date: 2011-03-14 Impact factor: 3.067
Authors: A Min Kang; Angela Padilla-Jones; Erik S Fisher; Jephte Y Akakpo; Hartmut Jaeschke; Barry H Rumack; Richard D Gerkin; Steven C Curry Journal: J Med Toxicol Date: 2019-11-25
Authors: Yuan Gao; Zhijun Cao; Xi Yang; Mohamed A Abdelmegeed; Jinchun Sun; Si Chen; Richard D Beger; Kelly Davis; William F Salminen; Byoung-Joon Song; Donna L Mendrick; Li-Rong Yu Journal: Proteomics Clin Appl Date: 2016-10-28 Impact factor: 3.494
Authors: Michael H Court; Zhaohui Zhu; Gina Masse; Su X Duan; Laura P James; Jerold S Harmatz; David J Greenblatt Journal: J Pharmacol Exp Ther Date: 2017-06-29 Impact factor: 4.030
Authors: Karen C Thomas; Diana G Wilkins; Steven C Curry; Todd C Grey; David M Andrenyak; Lawrence D McGill; Douglas E Rollins Journal: J Forensic Sci Date: 2016-08-01 Impact factor: 1.832
Authors: Sean M Frey; Timothy J Wiegand; Jody L Green; Kennon J Heard; Diana G Wilkins; Rachel M Gorodetsky; Richard C Dart Journal: J Med Toxicol Date: 2015-06
Authors: Dean W Roberts; William M Lee; Jack A Hinson; Shasha Bai; Christopher J Swearingen; R Todd Stravitz; Adrian Reuben; Lynda Letzig; Pippa M Simpson; Jody Rule; Robert J Fontana; Daniel Ganger; K Rajender Reddy; Iris Liou; Oren Fix; Laura P James Journal: Clin Gastroenterol Hepatol Date: 2016-09-15 Impact factor: 11.382
Authors: Sudeepa Bhattacharyya; Ke Yan; Lisa Pence; Pippa M Simpson; Pritmohinder Gill; Lynda G Letzig; Richard D Beger; Janice E Sullivan; Gregory L Kearns; Michael D Reed; James D Marshall; John N Van Den Anker; Laura P James Journal: Biomark Med Date: 2014 Impact factor: 2.851